These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34619837)

  • 1. [Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection].
    AIDS and Hepatitis C Professional Group, Chinese Society of Infectious Diseases
    Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):615-618. PubMed ID: 34619837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
    Salzman MB; Huang CW; O'Brien CM; Castillo RD
    Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID].
    Lee YJ; Kim SE; Park YE; Chang JY; Song HJ; Kim DH; Yang YJ; Kim BC; Lee JG; Yang HC; Choi M; Myung SJ;
    Korean J Gastroenterol; 2021 Aug; 78(2):117-128. PubMed ID: 34446634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection with HIV: clinical case series analysis in North Central Nigeria.
    Akyala AI; Iwu CJ
    Pan Afr Med J; 2020; 37():47. PubMed ID: 33209174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape and progress of global COVID-19 vaccine development.
    Huang HY; Wang SH; Tang Y; Sheng W; Zuo CJ; Wu DW; Fang H; Du Q; Li N
    Hum Vaccin Immunother; 2021 Oct; 17(10):3276-3280. PubMed ID: 34254894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.
    Sahin Tutak A; Söylemez F; Konuk HB; Çakmak E; Karakaya B; Doğan A; Sayiner HS; Aksöz S; Alev M
    J Infect Public Health; 2021 Oct; 14(10):1395-1397. PubMed ID: 34175235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune imprinting and SARS-CoV-2 vaccine design.
    Wheatley AK; Fox A; Tan HX; Juno JA; Davenport MP; Subbarao K; Kent SJ
    Trends Immunol; 2021 Nov; 42(11):956-959. PubMed ID: 34580004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to think about severe acute respiratory syndrome coronavirus 2 vaccination for pregnant and lactating women in China.
    Li P; Liu H; Zou Y; Fang M; Chen Y; Zhang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1386-1391. PubMed ID: 35232909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Considerations on vaccines and immunization against COVID-19 for epidemic control in China].
    Zhang Q; Wang FZ; Ma C; An ZJ; Yin ZD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1371-1376. PubMed ID: 34963231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
    Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
    Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
    Tscherne A; Schwarz JH; Rohde C; Kupke A; Kalodimou G; Limpinsel L; Okba NMA; Bošnjak B; Sandrock I; Odak I; Halwe S; Sauerhering L; Brosinski K; Liangliang N; Duell E; Jany S; Freudenstein A; Schmidt J; Werner A; Gellhorn Serra M; Klüver M; Guggemos W; Seilmaier M; Wendtner CM; Förster R; Haagmans BL; Becker S; Sutter G; Volz A
    Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34162739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus.
    Centonze D; Rocca MA; Gasperini C; Kappos L; Hartung HP; Magyari M; Oreja-Guevara C; Trojano M; Wiendl H; Filippi M
    J Neurol; 2021 Nov; 268(11):3961-3968. PubMed ID: 33844056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
    Yang Y; Iwasaki A
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):5-16. PubMed ID: 34843064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.